Form 4 holding
VP of Finance & Corp. Contr.
Werewolf Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 5,284
- Estimated value
- $3,381
- Report date
- 13 Feb 2026
- Price
- $0.6400
- Ownership
- Direct
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|